New York: 02:18 || London: 07:18 || Mumbai: 12:48 || Singapore: 15:18

News & Analysis » US

Protalix BioTherapeutics Names Tzvi Palash COO - Quick Facts

September 7, 2010, Tuesday, 14:05 GMT | 09:05 EST | 18:35 IST | 21:05 SGT

(RTTNews) - Protalix BioTherapeutics Inc. (PLX) announced the appointment of Tzvi Palash as the company's chief operating officer. The company added that Palash, with over 25 years of expertise in commercial operations in the healthcare industry, would be responsible for overseeing the company's manufacturing activities and implementing the expansion phase of its facility as it transitions from a research and development organization to a fully-integrated biotechnology company.

Prior to joining the company, he served as General Manager at ColBar LifeScience Ltd., an unit of Johnson & Johnson, Plant Manager at C.T.S., QA manager at Teva Pharmaceutical Industries and Production Manager at Interpharm Laboratories, a subsidiary of Serono.